GDC-0339
Product Specifications
CAS Number
1428569-85-0
Target
Pim
Related Pathways
Chromatin/Epigenetic, JAK/STAT signaling
Bioactivity
GDC-0339 is discovered as a potential treatment of multiple myeloma. GDC-0339 is an orally bioavailable and well-tolerated inhibitor of the pan-Pim kinase (Kis: 0.03 nM, 0.1 nM, and 0.02 nM for Pim1, Pim2, and Pim3, respectively) .
Smiles
Cn1ncc(NC(=O)c2nc(sc2N)-c2c(F)cccc2F)c1N1CC[C@@H](N)[C@H](F)CC1
Molecular Formula
C20H22F3N7OS
Molecular Weight
465.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15365142 1 Vial
Lentiviral human PDE9A sgRNA gene knockout kit - Lentiviral human PDE9A sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
MBS2117890-01 0.1 mL
PE-Linked Polyclonal Antibody to Phospholipase A2 Activating Protein (PLAP)
Sign In for Pricing
View Details MBS2117890-02 0.2 mL
PE-Linked Polyclonal Antibody to Phospholipase A2 Activating Protein (PLAP)
Sign In for Pricing
View Details MBS2117890-03 0.5 mL
PE-Linked Polyclonal Antibody to Phospholipase A2 Activating Protein (PLAP)
Sign In for Pricing
View Details MBS2117890-04 1 mL
PE-Linked Polyclonal Antibody to Phospholipase A2 Activating Protein (PLAP)
Sign In for Pricing
View Details MBS2117890-05 5 mL
PE-Linked Polyclonal Antibody to Phospholipase A2 Activating Protein (PLAP)
Sign In for Pricing
View Details